Who owns BOLT BIOTHERAPEUTICS INC?
- Ticker: BOLT
- CUSIP Number: 097702203
Tip: Access positions for across all investors
Analyze quarterly positions in Bolt Biotherapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Bolt Biotherapeutics stock
Who bought or sold BOLT BIOTHERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Sofinnova Ventures | 138k | $753k | 0% | Dec 2025 |
|
| Pivotal bioVenture Partners Investment Advisor | 95k | $517k | 0% | Dec 2025 |
|
| Vivo Capital | 72k | $396k | -59% | Dec 2025 |
|
| Nan Fung Group Holdings | 58k | $319k | 0% | Dec 2025 |
|
| Renaissance Technologies | 55k | $301k | 92% | Dec 2025 |
|
| Board of Trustees of The Leland Stanford Junior University | 36k | $197k | 0% | Dec 2025 |
|
| Pfizer | 31k | $171k | 0% | Dec 2025 |
|
| Nano Cap New Millennium Growth Fund | 21k | $112k | 100% | Dec 2025 |
|
| Geode Capital Management | 19k | $103k | 1% | Dec 2025 |
|
| None | 15k | $84k | 100% | Dec 2025 |
|
| Vanguard Group | 10k | $56k | -70% | Dec 2025 |
|
| BlackRock | 9.7k | $53k | 0% | Dec 2025 |
|
| Tower Research Capital | 723.00 | $4.0k | 179% | Dec 2025 |
|
| UBS Group | 515.00 | $2.8k | 17067% | Dec 2025 |
|
| Jpmorgan Chase & Co | 42.00 | $222.999000 | 100% | Sep 2025 |
|
| SBI Securities | 10.00 | $55.000000 | 0% | Dec 2025 |
|
| Barclays | 6.00 | $33.000000 | 0% | Dec 2025 |
|
Who sold out of Bolt Biotherapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Tang Capital Management | Sep 2025 | 67k | $356k |
| Samsara BioCapital | Sep 2025 | 49k | $260k |
| Susquehanna International | Sep 2025 | 17k | $89k |
| Shay Capital | Sep 2025 | 16k | $85k |
| Squarepoint Ops | Sep 2025 | 15k | $79k |
| DRW Holdings | Sep 2025 | 12k | $66k |
| FMR | Jun 2025 | 121.00 | $704.994400 |